Oligoarticular juvenile idiopathic arthritis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — High-dose systemic glucocorticoid plus infliximab or another effective steroid-sparing ocular immunosuppressant
Explanation lettering: E = shown as A · A = shown as B · B = shown as C · C = shown as D · D = shown as E
D is correct. EULAR treats sight-threatening posterior uveitis as an emergency requiring systemic glucocorticoid together with potent immunosuppression; infliximab or interferon-alpha are established severe-ocular options, with azathioprine or ciclosporin used according to the wider course. A is inadequate for posterior disease. B does not control retinal vasculitis. C uses the TNF construct with weaker ocular efficacy. E ignores inflammatory vessel-wall disease and risks bleeding without controlling Behçet activity.
Reference: EULAR recommendations for management of Behçet syndrome: https://ard.bmj.com/content/77/6/808